Singapore: Shasun Pharmaceuticals and Debiopharm Group entered into a licensing agreement for the manufacturing and commercialization of Huperzine-A. The drug is a potent and reversible acetylcholinesterase inhibitor which significantly... Read more
Singapore: For the first time, the US FDA has completed an inspection in China under its combined clinical trial and bioresearch... Read more
Singapore: Japan-headquartered Ajinomoto has entered into a definitive agreement to acquire Althea Technologies, a US-based... Read more
Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its network of manufacturing... Read more
Mumbai: India-based Inventys Research has received ISO 9001:2008 management system accreditation from the Indian Registrar of Quality Systems... Read more
After five years of amendments and two rounds of public consultations, the State Food and Drug Administration (SFDA) issued Good Manufacturing... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
